Odevixibat, a small molecule that inhibits ileal resorption of BAs belonging to the class of ileal BAs transporter (IBAT) inhibitors, was the first drug approved for the treatment of PFIC patients 6 months old due to its efficacy on both pruritus and reduction of serum BAs as well as its good tolerability in 2021 [16]
Conclusion Tesamorelin and Ipamorelin form a potent peptide combination that mimics the bodys natural growth hormone stimulation in a safe, effective, and targeted manner
1 Injection Technique : Inject into the abdomen, avoiding the navel, scar tissue, or bruised areas
Herzenberg LA, De Rosa SC, Dubs JG, Roederer M, Anderson MT, Ela SW, Deresinski SC, Herzenberg LA
[9] Healthcare providers and laboratory personnel should be aware the patient is on sermorelin, so that lab results are interpreted appropriately